Nav: Home

Catch a virus by its tail

May 13, 2019

Viruses are masterful invaders. They cannibalize host cells by injecting their genetic material, often making thousands of copies of themselves in a single cell to ensure their replication and survival.

Some RNA viruses insert their genetic material as a single piece, while others chop it up into pieces. The latter are aptly named segmented viruses.

Such segmented RNA viruses--including several that cause human diseases like influenza--have been a longstanding enigma to researchers: How do they accomplish the precise copying and insertion of each segment? How do they ensure that individual segments are all copied by the same enzyme while ensuring that each segment can make different amounts of RNA? Such exquisite regulation is critical to make the correct levels of the viral proteins necessary for successful replication.

Now research by scientists at Harvard Medical School's Blavatnik Institute yields a surprising answer: The viral machinery in charge of this survival-ensuring maneuver becomes activated by an RNA from the opposite end of the segment where copying starts.

The findings, published May 9 in PNAS, identify new potential targets to inhibit the replication of segmented viruses. This group includes several emerging and highly fatal viruses such as Lassa fever virus, bunyaviruses like La Crosse and Rift Valley fever, as well as the better known and more common influenza viruses.

"Climate change has altered and intensified the spread of some serious and emerging viruses to new geographic regions, creating an acute challenge to global health. Our findings identify a critical mechanism that allows some of these pathogens to replicate and survive," said Sean P. J. Whelan, professor of microbiology at HMS and director of the Harvard Program in Virology.

Lassa fever infections, for example, are rarely fatal, but once actual disease develops, it can cause hemorrhages, or bleeding, in multiple organs in one out of five people. The mortality rate can reach 50 percent during epidemics, according to the Centers for Disease Control and Prevention.

In the study, Whelan and study co-author Jesse Pyle, a graduate student in Whelan's lab, worked with the Machupo virus, an arenavirus, which like Lassa virus infects rodents that in turn transmit the virus to humans where it causes fatal hemorrhagic fevers.

Unlike the flu virus, whose genome has eight segments, Machupo virus has only two segments--called small and large segments--offering a much simpler way to understand how different segments are copied in the correct amounts.

Previous clues about this mechanism came from research on influenza and La Crosse viruses that showed the viral protein responsible for copying the key segment--RNA-dependent RNA-polymerase (RdRP)--interacts with the 5' end of the segment, which is the exact opposite end to the location where the protein initiates copying. Yet, the importance of this interaction was not fully understood.

The experiments revealed that mixing short 13-nucleotide long RNAs from the 5' end of the Machupo virus segments with the RdRP--the catalyst that initiates RNA replication--in fact, stimulated the ability of this enzyme to copy the viral segment. The two-segment Machupo virus contains four subtly different 5' RNAs that each bind the RdRP enzyme. Remarkably, the scientists observed, those RNAs dictate which of the four different start sites the enzyme actually uses.

Whelan and Pyle say these results not only shed light on an important question in basic virology, but they also identify a new target that may illuminate how to develop of a new class of antiviral drugs that target this essential 5' RNA activation.

Most antiviral drugs currently on the market directly target viral enzymes involved in replicating genetic material or in the processing of viral proteins. None, however, interfere with the particular mechanism described in the current study.

"Our work demonstrates that both the 5' RNA and its binding site on the viral enzyme are potential new targets for inhibition of viral replication," Whelan said. "An important next goal would be to hunt for molecules that interfere with this process and set the stage for new drug design."
-end-
This research was funded by National Institutes of Health (grants AI133689, T32AI007245 and AI059371).

Paper DOI: https://doi.org/10.1073/pnas.1900790116

Harvard Medical School

Related Rna Articles:

How RNA formed at the origins of life
A single process for how a group of molecules called nucleotides were made on the early Earth, before life began, has been suggested by a UCL-led team of researchers.
RNA and longevity: Discovering the mechanisms behind aging
Korean researchers suggests that NMD-mediated RNA quality control is critical for longevity in the roundworm called C. elegans, a popularly used animal for aging research.
Don't kill the messenger RNA
Success of new protein-making therapy for hemophilia opens door for treating many other diseases.
RNA modification important for brain function
Researchers at the Institute of Molecular Biology (IMB) and Johannes Gutenberg University Mainz (JGU) have shown that a new way of regulating genes is vital for the activity of the nervous system.
Atlas of the RNA universe takes shape
In the last few years, small snippets of RNA, which may have played a key role in the planet's earliest flickering of life, have been uncovered and examined in great detail.
Punching cancer with RNA knuckles
Researchers achieved an unexpected eye-popping reduction of ovarian cancer during successful tests of targeted nanohydrogel delivery in vivo in mice.
Gatekeeping proteins to aberrant RNA: You shall not pass
Berkeley Lab researchers found that aberrant strands of genetic code have telltale signs that enable gateway proteins to recognize and block them from exiting the nucleus.
Short RNA molecules mapped in single cell
Researchers at Karolinska Institutet have measured the absolute numbers of short, non-coding, RNA sequences in individual embryonic stem cells.
Watching RNA fold
New technology takes a nucleotide-resolution snapshot of RNA as it is folding, which could lead to discoveries in biology, gene expression, and disease.
Bacteria: Third RNA binding protein identified
Pathogenic bacteria use small RNA molecules to adapt to their environment.

Related Rna Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Anthropomorphic
Do animals grieve? Do they have language or consciousness? For a long time, scientists resisted the urge to look for human qualities in animals. This hour, TED speakers explore how that is changing. Guests include biological anthropologist Barbara King, dolphin researcher Denise Herzing, primatologist Frans de Waal, and ecologist Carl Safina.
Now Playing: Science for the People

#SB2 2019 Science Birthday Minisode: Mary Golda Ross
Our second annual Science Birthday is here, and this year we celebrate the wonderful Mary Golda Ross, born 9 August 1908. She died in 2008 at age 99, but left a lasting mark on the science of rocketry and space exploration as an early woman in engineering, and one of the first Native Americans in engineering. Join Rachelle and Bethany for this very special birthday minisode celebrating Mary and her achievements. Thanks to our Patreons who make this show possible! Read more about Mary G. Ross: Interview with Mary Ross on Lash Publications International, by Laurel Sheppard Meet Mary Golda...